Managers
A total of 298 European private equity transactions in Q3 represented a meaningful reduction in volume over the prior quarter, impacted by a decrease in both buyouts and early stage transactions, according to SL Capital Partners.
Value held up relatively well given the reduced volumes and, although the EUR19.0bn transacted was a 19.7 per cent reduction on the prior quarter, the overall performance was much higher than Q3 2013 and 2012 and average deal size remained stable.
The European private equity market continues to move in a general upward trend, although continuing to experience a high level of volatility
Independent corporate and fund services provider Crestbridge has seen the value of funds it administers grow from GBP1.84 billion in June 2013 to GBP15.06 billion in June 2014, representing an increase of more than 700 per cent.
Contributing to this growth were a number of key business wins for the firm. These included establishing and providing administration services to the Jersey-domiciled Kennedy Wilson European Real Estate fund, which raised GBP1 billion and became the second largest real estate IPO in LSE history, and being appointed to provide a range of administration and oversight services to a number of Jersey-domiciled asset
London listed private equity fund JZ Capital Partners, an investor in US and European micro cap companies, has now seen NAV growth in 20 of the past 22 quarters.
The firm’s NAV totalled USD657.4 million at 31 August 2014 (FYE 28/02/14: USD666.5 million), with pre-dividend NAV per share of USD10.27 (FYE 28/02/14: USD10.25). A distribution of 16 cents per share was paid in June 2014, while an interim dividend of 15 cents per share was paid for the period (H1 2013: 14.5 cents per share).
The firm saw USD96.4 million of proceeds during the period, primarily from the following realisations:
Platinum Equity has acquired a majority interest in ground engineering firm Grupo Terratest.
Financial terms of the transaction have not been disclosed.
Headquartered in Madrid and providing services around the world, Terratest is a specialised international contractor providing foundation work, ground improvement and micro-tunnelling services for large-scale infrastructure projects and industrial, commercial and residential construction.
Platinum Equity is a global private equity firm currently investing from a USD3.75 billion buyout fund focused on acquiring businesses that can benefit from the firm's operational expertise.
"Terratest is a leader in its industry with a well-recognised brand, strong management, talented
V-Rooms has announced the pre-launch of Global Deal Market, a rated deal marketplace exclusively for family office direct investments in private US based mature companies, typically with annual up to USD100 million.
With this pre-launch, Global Deal Market (GDM) is actively reviewing M&A deals for presentation to its Charter Member Investors. With the public launch in January, GDM will present a wide assortment of deals to over 300 family offices.
Global Deal Market will be a deal rating and matching service for partnered family office investors and ultra high-net-worth individuals who are interested in owning private US based mature
Cirque Energy has entered into a USD5 million common stock purchase agreement with Kodiak Capital Group, a Newport Beach, California-based institutional investor.
Cirque has agreed to file a registration statement with the US Securities and Exchange Commission covering the shares that may be issued to Kodiak under the terms of the common stock purchase agreement.
After the SEC has declared the registration statement related to the transaction effective, Cirque will have the right at its sole discretion over a period of one year to sell up to USD5 million of common stock under the terms set forth in the
Carne Group has received authorisation for an independent AIFMD-compliant management company in the Channel Islands.
The new management company has become immediately operational with Carne Group’s fund clients. It is particularly suitable for alternative fund managers, including credit, hedge fund, private equity, infrastructure and real estate investment firms.
Carne has received authorisation as a fund services business from the Jersey regulator, the Jersey Financial Services Commission (JFSC).
Carne already has over 20 clients making use of its AIFMD management company solutions in Ireland and Luxembourg. The Jersey management company is the first to be approved outside the European
Advent Life Sciences has closed its Advent Life Sciences Fund II (ALSF II), a GBP145.5 million (USD235 million) venture capital fund raised to seed and build life sciences companies in the UK, Europe and the US.
The fund will back entrepreneurs and early-stage and mid-stage companies with the potential to deliver first- or best-in-class breakthrough products for unmet medical needs.
The fund, which quickly exceeded its target, was raised entirely from independent financial investors including funds-of-funds, pension funds, and family offices.
“We thank our returning and new LPs for the strength of their support, which allowed us to
Infracapital, the infrastructure investment arm of M&G Investments and parent Prudential plc, has reached a final closing of its latest fund, Infracapital Partners II, with total commitments of GBP1.0 billion (USD1.6 billion).
Co-investment pledges take the total investable funds to over GBP1.3 billion. As with its predecessor, Infracapital Partners LP, the fund’s strategy is to invest in, and actively manage, core infrastructure assets across Europe.
The fundraising, which exceeded its initial target, received strong backing from existing investors and in addition welcomed a number of new investors from across Europe, North America and Asia. In addition to seed capital
Private equity firm GTCR is to sell portfolio company Devicor Medical Products to Danaher Corporation’s Leica Biosystems, a provider of anatomical pathology solutions and automation used to advance cancer diagnostics.
Devicor is a medical device company specialising in products for use in breast biopsy procedures. The company is the global market leader in the vacuum-assisted biopsy segment of the breast biopsy market. Its products include the Mammotome Breast Biopsy System, tissue markers and related products, which, to date, have enabled more than four million women to have a minimally invasive breast biopsy.
Devicor began as a management partnership formed
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
